IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 89 filers reported holding IMMUNOVANT INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,325,512 | +16.1% | 1,102,514 | -42.6% | 2.01% | +44.0% |
| Q2 2023 | $36,444,253 | +78.4% | 1,921,152 | +45.9% | 1.40% | +57.9% |
| Q1 2023 | $20,427,151 | +5.8% | 1,317,031 | +21.0% | 0.89% | +12.2% |
| Q4 2022 | $19,314,325 | +353.8% | 1,088,131 | +799.7% | 0.79% | +912.8% |
| Q3 2020 | $4,256,000 | -70.9% | 120,940 | -79.8% | 0.08% | -71.1% |
| Q2 2020 | $14,610,000 | – | 600,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |